An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

被引:102
|
作者
Davi, Sergio [1 ]
Consolaro, Alessandro [1 ]
Guseinova, Dinara [1 ]
Pistorio, Angela [1 ]
Ruperto, Nicolino [1 ]
Martini, Alberto [1 ,2 ]
Cron, Randy Q. [3 ,4 ]
Ravelli, Angelo [1 ,2 ]
机构
[1] Ist Ricovero & Cura Carattere Sci G Gaslini, Genoa, Italy
[2] Univ Genoa, Genoa, Italy
[3] Childrens Hosp Alabama, Birmingham, AL USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
关键词
MACROPHAGE ACTIVATION SYNDROME; HEMOPHAGOCYTIC SYNDROME; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; DIAGNOSTIC CRITERIA; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; DERMATOMYOSITIS; GUIDELINES;
D O I
10.3899/jrheum.100996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To identify candidate diagnostic criteria for macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (sJIA) using international consensus formation through a Delphi questionnaire survey. Methods. A questionnaire listing 28 clinical, laboratory, and histopathologic features of MAS elicited by literature review was sent to 505 pediatric rheumatologists worldwide. Respondents were asked to select the 10 features that they felt were most important and useful in the diagnosis of MAS, and to order the 10 selected features by assigning the number 10 to the most important, and ending with 1 as the least important. Results. The response rate was 46% (232 physicians from 47 countries). The items selected by more than 50% of respondents were, in order of frequency, falling platelet count, hyperferritinemia, evidence of macrophage hemophagocytosis in the bone marrow, increased liver enzymes, falling leukocyte count, persistent continuous fever >= 38 degrees C, falling erythrocyte sedimentation rate, hypofibrinogenemia, and hypertriglyceridemia. Conclusion. Our process led to identification of features that were felt to be most important as candidate diagnostic criteria for MAS by a large sample of international pediatric rheumatologists. (First Release Feb 1 2011; J Rheumatol 2011;38:764-8: doi:10.3899/jrheum.100996)
引用
收藏
页码:764 / 768
页数:5
相关论文
共 50 条
  • [1] Macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Shimizu, Masaki
    IMMUNOLOGICAL MEDICINE, 2021, 44 (04) : 237 - 245
  • [2] Dissecting the Heterogeneity of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
    Minoia, Francesca
    Davi, Sergio
    Horne, AnnaCarin
    Bovis, Francesca
    Demirkaya, Erkan
    Akikusa, Jonathan
    Ayaz, Nuray A.
    Al-Mayouf, Sulaiman M.
    Barone, Patrizia
    Bica, Bianca
    Bolt, Isabel
    Breda, Luciana
    De Cunto, Carmen
    Enciso, Sandra
    Gallizzi, Romina
    Griffin, Thomas
    Hennon, Teresa
    Horneff, Gerd
    Jeng, Michael
    Kapovic, Ageza M.
    Lipton, Jeffrey M.
    Manzoni, Silvia Magni
    Rumba-Rozenfelde, Ingrida
    Magalhaes, Claudia Saad
    Sewairi, Wafaa M.
    Stine, Kimo C.
    Vougiouka, Olga
    Weaver, Lehn K.
    Davidsone, Zane
    De Inocencio, Jaime
    Ioseliani, Maka
    Lattanzi, Bianca
    Tezer, Hasan
    Buoncompagni, Antonella
    Picco, Paolo
    Ruperto, Nicolino
    Martini, Alberto
    Cron, Randy Q.
    Ravelli, Angelo
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 994 - 1001
  • [3] Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis
    Behrens, Edward M.
    Beukelman, Timothy
    Paessler, Michele
    Cron, Randy Q.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (05) : 1133 - 1138
  • [4] Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan
    Shimizu, Masaki
    Nishimura, Kenichi
    Iwata, Naomi
    Yasumi, Takahiro
    Umebayashi, Hiroaki
    Nakagishi, Yasuo
    Okura, Yuka
    Okamoto, Nami
    Kinjo, Noriko
    Mizuta, Mao
    Yashiro, Masato
    Yasumura, Junko
    Wakiguchi, Hiroyuki
    Kubota, Tomohiro
    Mouri, Mariko
    Kaneko, Utako
    Mori, Masaaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (05) : 938 - 945
  • [5] Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
    Inoue, Natsumi
    Schulert, Grant S.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [6] Macrophage activation syndrome and systemic onset of juvenile idiopathic arthritis
    Iglesias Jimenez, E.
    Camacho Lovillo, M. S.
    Lirola Cruz, M. J.
    Falcon Neyra, D.
    Neth, O.
    ANALES DE PEDIATRIA, 2010, 72 (03): : 230 - 231
  • [7] Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era
    Ailioaie, Laura Marinela
    Ailioaie, Constantin
    Litscher, Gerhard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [8] Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
    Yokota, Shumpei
    Itoh, Yasuhiko
    Morio, Tomohiro
    Sumitomo, Naokata
    Daimaru, Kaori
    Minota, Seiji
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (04) : 712 - 722
  • [9] Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis
    Moreira Gomes Tavares, Anna Carolina Faria
    Ferreira, Gilda Aparecida
    Guimaraes, Luciano Junqueira
    Guimaraes, Raquel Rosa
    Sena Teixeira Santos, Flavia Patricia
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2015, 55 (01) : 79 - 82
  • [10] Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus
    Aytac, Selin
    Batu, Ezgi Deniz
    Unal, Sule
    Bilginer, Yelda
    Cetin, Mualla
    Tuncer, Murat
    Gumruk, Fatma
    Ozen, Seza
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (10) : 1421 - 1429